|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2002-1-21
|
|
pubmed:abstractText |
Autologous stem cell transplantation is a therapeutic option for chronic myeloid leukemia (CML) patients who are not candidates for allogeneic transplant. To reduce the risk of post-autografting disease recurrence, different strategies of stem cell selection have been attempted. The results of using recombinant human granulocyte colony-stimulating factor (rHuG-CSF) for harvesting hematopoietic progenitors in CML patients treated with interferon-a (IFN) are reported.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0390-6078
|
|
pubmed:author |
pubmed-author:Arellano-RodrigoEduardoE,
pubmed-author:CarrerasEnricE,
pubmed-author:CervantesFranciscoF,
pubmed-author:EspinetBlancaB,
pubmed-author:Hernández-BoludaJuan-CarlosJC,
pubmed-author:LloverasElisabetE,
pubmed-author:MarínPedroP,
pubmed-author:MontserratEmiliE,
pubmed-author:OcejoAgustínA,
pubmed-author:RoviraMontserratM,
pubmed-author:SoléFrancescF
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
87
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
17-22
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11801461-Adolescent,
pubmed-meshheading:11801461-Adult,
pubmed-meshheading:11801461-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11801461-Blood Cell Count,
pubmed-meshheading:11801461-Blood Component Removal,
pubmed-meshheading:11801461-Bone Marrow Purging,
pubmed-meshheading:11801461-Busulfan,
pubmed-meshheading:11801461-Cytarabine,
pubmed-meshheading:11801461-Feasibility Studies,
pubmed-meshheading:11801461-Female,
pubmed-meshheading:11801461-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:11801461-Hematopoietic Stem Cell Mobilization,
pubmed-meshheading:11801461-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:11801461-Hematopoietic Stem Cells,
pubmed-meshheading:11801461-Humans,
pubmed-meshheading:11801461-Hydroxyurea,
pubmed-meshheading:11801461-Immunologic Factors,
pubmed-meshheading:11801461-Interferons,
pubmed-meshheading:11801461-Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
pubmed-meshheading:11801461-Leukocytosis,
pubmed-meshheading:11801461-Male,
pubmed-meshheading:11801461-Middle Aged,
pubmed-meshheading:11801461-Neoplastic Cells, Circulating,
pubmed-meshheading:11801461-Pain,
pubmed-meshheading:11801461-Philadelphia Chromosome,
pubmed-meshheading:11801461-Recombinant Proteins,
pubmed-meshheading:11801461-Remission Induction,
pubmed-meshheading:11801461-Safety,
pubmed-meshheading:11801461-Transplantation, Autologous,
pubmed-meshheading:11801461-Treatment Outcome
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Collection of Philadelphia-negative stem cells using recombinant human granulocyte colony-stimulating factor in chronic myeloid leukemia patients treated with alpha-interferon.
|
|
pubmed:affiliation |
BMT Unit, Institute of Hematology and Oncology, Department of Hematology, Hospital del Mar, Villaroel 170, 08036 Barcelona, Spain.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|
